Marie-Louise Fjällskog
Physician at Department of Medical Sciences; Endocrine Oncology
- E-mail:
- Marie-Louise.Fjallskog@medsci.uu.se
- Visiting address:
- Rudbecklaboratoriet, R3, 2 tr
751 85 UPPSALA - Postal address:
- Rudbecklaboratoriet, R3, 2 tr
751 85 UPPSALA
Publications
Recent publications
-
Taxane-induced pain in breast cancer patients as perceived by nurses
Part of Acta Oncologica, p. 412-418, 2021
-
Part of Scandinavian Journal of Pain, p. 581-591, 2018
-
Ghrelin expression is associated with a favorable outcome in male breast cancer
Part of Scientific Reports, 2018
- DOI for Ghrelin expression is associated with a favorable outcome in male breast cancer
- Download full text (pdf) of Ghrelin expression is associated with a favorable outcome in male breast cancer
-
Part of Clinical Cancer Research, p. 2575-2583, 2017
-
Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer
Part of PLOS ONE, 2017
- DOI for Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer
- Download full text (pdf) of Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer
All publications
Articles in journal
-
Taxane-induced pain in breast cancer patients as perceived by nurses
Part of Acta Oncologica, p. 412-418, 2021
-
Ghrelin expression is associated with a favorable outcome in male breast cancer
Part of Scientific Reports, 2018
- DOI for Ghrelin expression is associated with a favorable outcome in male breast cancer
- Download full text (pdf) of Ghrelin expression is associated with a favorable outcome in male breast cancer
-
Part of Clinical Cancer Research, p. 2575-2583, 2017
-
Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer
Part of PLOS ONE, 2017
- DOI for Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer
- Download full text (pdf) of Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer
-
Part of Breast Cancer Research and Treatment, p. 667-678, 2017
- DOI for High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers
- Download full text (pdf) of High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers
-
Part of Cancer Nursing, p. 464-472, 2016
- DOI for Women Treated for Breast Cancer, Experiences of Chemotherapy-Induced Pain: Memories, Any Present Pain and Future reflections
- Download full text (pdf) of Women Treated for Breast Cancer, Experiences of Chemotherapy-Induced Pain: Memories, Any Present Pain and Future reflections
-
Nuclear osteopontin-c is a prognostic breast cancer marker
Part of British Journal of Cancer, p. 729-738, 2015
-
Women With Breast Cancer: Experience of Chemotherapy-Induced Pain: Triangulation of Methods
Part of Cancer Nursing, p. 31-39, 2015
-
Part of Acta Oncologica, p. 538-544, 2015
-
Part of Molecular Oncology, p. 1565-1579, 2015
- DOI for Genome methylation patterns in male breast cancer - Identification of an epitype with hypermethylation of polycomb target genes
- Download full text (pdf) of Genome methylation patterns in male breast cancer - Identification of an epitype with hypermethylation of polycomb target genes
-
Part of International Journal of Breast Cancer, 2014
-
Nuclear HIF1A expression is strongly prognostic in sporadic but not familial male breast cancer
Part of Modern Pathology, p. 1223-1230, 2014
-
Women with breast cancer: Experiences and impact of chemotherapy-induced pain on daily life
Part of European Journal of Cancer, 2014
-
Part of BMC Cancer, p. 512, 2013
- DOI for Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study
- Download full text (pdf) of Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study
-
Part of International Journal of Breast Cancer, 2013
- DOI for A Comparison of Tumor Biology in Primary Ductal Carcinoma In Situ Recurring as Invasive Carcinoma versus a New In Situ
- Download full text (pdf) of A Comparison of Tumor Biology in Primary Ductal Carcinoma In Situ Recurring as Invasive Carcinoma versus a New In Situ
-
Part of SpringerPlus, 2013
- DOI for The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naive women with N0/N1 primary breast cancer
- Download full text (pdf) of The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naive women with N0/N1 primary breast cancer
-
Part of PLOS ONE, 2013
- DOI for The Prognostic Value of Mitotic Activity Index (MAI), Phosphohistone H3 (PPH3), Cyclin B1, Cyclin A, and Ki67, Alone and in Combinations, in Node-Negative Premenopausal Breast Cancer
- Download full text (pdf) of The Prognostic Value of Mitotic Activity Index (MAI), Phosphohistone H3 (PPH3), Cyclin B1, Cyclin A, and Ki67, Alone and in Combinations, in Node-Negative Premenopausal Breast Cancer
-
High proliferation is associated with inferior outcome in male breast cancer patients
Part of Modern Pathology, p. 87-94, 2013
-
Molecular subtyping of male breast cancer using alternative definitions and its prognostic impact
Part of Acta Oncologica, p. 102-109, 2013
-
Part of BMC Cancer, p. 167, 2012
- DOI for How can health care help female breast cancer patients reduce their stress symptoms?: A randomized intervention study with stepped-care
- Download full text (pdf) of How can health care help female breast cancer patients reduce their stress symptoms?: A randomized intervention study with stepped-care
-
Part of Breast Cancer Research, 2012
- DOI for Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker
- Download full text (pdf) of Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker
-
Inflammatory cells in node-negative breast cancer
Part of Acta Oncologica, p. 680-686, 2012
-
Part of Breast Cancer Research and Treatment, p. 33-40, 2012
-
Expression of ghrelin is correlated to a favorable outcome in invasive breast cancer
Part of Acta Oncologica, p. 386-393, 2012
-
Part of Breast Cancer Research and Treatment, p. 747-760, 2011
-
Part of Acta Oncologica, p. 1083-1088, 2011
-
Part of International Journal of Cancer, p. 961-967, 2010
-
Part of Acta Oncologica, p. 816-820, 2010
-
Part of Läkartidningen, p. 672-675, 2010
-
Cyclin A is a proliferative marker with good prognostic value in node-negative breast cancer
Part of Cancer Epidemiology, Biomarkers and Prevention, p. 2501-2506, 2009
-
Aberrant expression of cyclin E in low-risk node negative breast cancer
Part of Acta Oncologica, p. 1539-1545, 2008
-
Ki67 and cyclin A as prognostic factors in early breast cancer: What are the optimal cut-off values?
Part of Histopathology, p. 491-498, 2007
-
Part of Acta Oncologica, p. 741-746, 2007
-
Part of British Journal of Cancer, p. 1697-1702, 2006
-
Treatment of endocrine pancreatic tumors
Part of Acta Oncologica, p. 329-338, 2005
-
Breast cancer on the Internet: the quality of Swedish breast cancer websites.
Part of The Breast, p. 376-82, 2004
-
Autobiographical memories in patients treated for breast cancer.
Part of J Psychosom Res, p. 363-6, 2004
-
Part of Medical Oncology, p. 59-67, 2003
-
Part of Med Oncol, p. 35-42, 2002
-
Experience in treatment of metastatic pulmonary carcinoid tumors
Part of Annals of Oncology, p. 1383-1391, 2001
-
Treatment with Cisplatin and Etoposide in Patients with Neuroendocrine Tumors
Part of Cancer, p. 1101-1107, 2001
-
Part of Eur J Cancer, p. 687-90, 1994
-
Is Cremophor EL, solvent for paclitaxel, cytotoxic?
Part of Lancet, p. 873, 1993
-
Nurses’ experiences of taxane-induced pain in people treated for breast cancer
Articles, review/survey
-
Part of Scandinavian Journal of Pain, p. 581-591, 2018
-
Tratamento dos tumores endócrinos do pâncreas.
Part of Câncer Hoje- A Oncologia baseada em Evidência., p. 17-25, 2004